Roblitinib (FGF401)
98%
- Product Code: 102361
CAS:
1708971-55-4
| Molecular Weight: | 506.56 g./mol | Molecular Formula: | C₂₅H₃₀N₈O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD31381923 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Roblitinib (FGF401) is primarily investigated for its potential in cancer treatment, particularly targeting tumors with fibroblast growth factor receptor 4 (FGFR4) overexpression. It is being studied in clinical trials for its efficacy in treating hepatocellular carcinoma (HCC) and other solid tumors where FGFR4 signaling plays a critical role. The compound works by inhibiting FGFR4, which helps in reducing tumor growth and progression. Its application is focused on patients who may not respond to conventional therapies, offering a targeted approach to manage specific cancer types.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿12,450.00 |
+
-
|
Roblitinib (FGF401)
Roblitinib (FGF401) is primarily investigated for its potential in cancer treatment, particularly targeting tumors with fibroblast growth factor receptor 4 (FGFR4) overexpression. It is being studied in clinical trials for its efficacy in treating hepatocellular carcinoma (HCC) and other solid tumors where FGFR4 signaling plays a critical role. The compound works by inhibiting FGFR4, which helps in reducing tumor growth and progression. Its application is focused on patients who may not respond to conventional therapies, offering a targeted approach to manage specific cancer types.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :